These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


258 related items for PubMed ID: 16979918

  • 21. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
    Millatt LJ, Whitley GS, Li D, Leiper JM, Siragy HM, Carey RM, Johns RA.
    Circulation; 2003 Sep 23; 108(12):1493-8. PubMed ID: 12952847
    [Abstract] [Full Text] [Related]

  • 22. Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells.
    Novella S, Laguna-Fernández A, Lázaro-Franco M, Sobrino A, Bueno-Betí C, Tarín JJ, Monsalve E, Sanchís J, Hermenegildo C.
    Mol Cell Endocrinol; 2013 Jan 05; 365(1):11-6. PubMed ID: 22982060
    [Abstract] [Full Text] [Related]

  • 23. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.
    Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP.
    Circulation; 1999 Jun 22; 99(24):3092-5. PubMed ID: 10377069
    [Abstract] [Full Text] [Related]

  • 24. Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury.
    Konishi H, Sydow K, Cooke JP.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1099-105. PubMed ID: 17349891
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T.
    Vasc Med; 2013 Aug 13; 18(4):192-9. PubMed ID: 23892448
    [Abstract] [Full Text] [Related]

  • 27. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
    Jiang JL, Zhang XH, Li NS, Rang WQ, Feng-Ye, Hu CP, Li YJ, Deng HW.
    Cardiovasc Drugs Ther; 2006 Aug 13; 20(4):281-94. PubMed ID: 16897158
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
    Anderssohn M, Maass LM, Diemert A, Lüneburg N, Atzler D, Hecher K, Böger RH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr 13; 161(2):152-6. PubMed ID: 22285683
    [Abstract] [Full Text] [Related]

  • 30. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence.
    Dayoub H, Achan V, Adimoolam S, Jacobi J, Stuehlinger MC, Wang BY, Tsao PS, Kimoto M, Vallance P, Patterson AJ, Cooke JP.
    Circulation; 2003 Dec 16; 108(24):3042-7. PubMed ID: 14638548
    [Abstract] [Full Text] [Related]

  • 31. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase.
    Achan V, Tran CT, Arrigoni F, Whitley GS, Leiper JM, Vallance P.
    Circ Res; 2002 Apr 19; 90(7):764-9. PubMed ID: 11964368
    [Abstract] [Full Text] [Related]

  • 32. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M, Marchegiani F, Ceriello A, Sirolla C, Boemi M, Franceschi C, Spazzafumo L, Testa I, Bonfigli AR, Cucchi M, Testa R.
    Nephrol Dial Transplant; 2013 Apr 19; 28(4):964-71. PubMed ID: 23129820
    [Abstract] [Full Text] [Related]

  • 33. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
    Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP.
    Circulation; 2002 Aug 20; 106(8):987-92. PubMed ID: 12186805
    [Abstract] [Full Text] [Related]

  • 34. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
    Lange C, Mowat F, Sayed H, Mehad M, Duluc L, Piper S, Luhmann U, Nandi M, Kelly P, Smith A, Ali R, Leiper J, Bainbridge J.
    Exp Eye Res; 2016 Jun 20; 147():148-155. PubMed ID: 27181226
    [Abstract] [Full Text] [Related]

  • 35. Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
    Torondel B, Nandi M, Kelly P, Wojciak-Stothard B, Fleming I, Leiper J.
    Vasc Med; 2010 Jun 20; 15(3):205-13. PubMed ID: 20219849
    [Abstract] [Full Text] [Related]

  • 36. Dimethylarginine dimethylaminohydrolase 2 increases vascular endothelial growth factor expression through Sp1 transcription factor in endothelial cells.
    Hasegawa K, Wakino S, Tanaka T, Kimoto M, Tatematsu S, Kanda T, Yoshioka K, Homma K, Sugano N, Kurabayashi M, Saruta T, Hayashi K.
    Arterioscler Thromb Vasc Biol; 2006 Jul 20; 26(7):1488-94. PubMed ID: 16574895
    [Abstract] [Full Text] [Related]

  • 37. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
    Selley ML.
    J Neurosci Res; 2004 Jul 01; 77(1):90-3. PubMed ID: 15197741
    [Abstract] [Full Text] [Related]

  • 38. Phosphorylation of Nonmuscle Myosin Light Chain Promotes Endothelial Injury in Hyperlipidemic Rats Through a Mechanism Involving Downregulation of Dimethylarginine Dimethylaminohydrolase 2.
    Wu Y, Zhang JJ, Li TB, Liu WQ, Li LS, Luo XJ, Jiang JL, Ma QL, Yang ZC, Peng J.
    J Cardiovasc Pharmacol Ther; 2016 Nov 01; 21(6):536-548. PubMed ID: 26911182
    [Abstract] [Full Text] [Related]

  • 39. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, Itoh H.
    Circ Res; 2007 Jul 20; 101(2):e2-10. PubMed ID: 17601800
    [Abstract] [Full Text] [Related]

  • 40. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK, Dasari C, Duscharla D, Supriya B, Ram NS, Surekha MV, Kumar JM, Ummanni R.
    Angiogenesis; 2018 Feb 20; 21(1):79-94. PubMed ID: 29150732
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.